Health Catalyst (HCAT) Research & Development (2018 - 2025)
Historic Research & Development for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to $12.3 million.
- Health Catalyst's Research & Development fell 1347.14% to $12.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.9 million, marking a year-over-year decrease of 1324.4%. This contributed to the annual value of $58.0 million for FY2024, which is 2020.87% down from last year.
- Per Health Catalyst's latest filing, its Research & Development stood at $12.3 million for Q3 2025, which was down 1347.14% from $12.4 million recorded in Q2 2025.
- In the past 5 years, Health Catalyst's Research & Development registered a high of $20.8 million during Q3 2022, and its lowest value of $12.3 million during Q3 2025.
- Its 5-year average for Research & Development is $16.3 million, with a median of $16.4 million in 2021.
- As far as peak fluctuations go, Health Catalyst's Research & Development soared by 2676.23% in 2022, and later tumbled by 2605.48% in 2024.
- Over the past 5 years, Health Catalyst's Research & Development (Quarter) stood at $17.5 million in 2021, then grew by 12.21% to $19.6 million in 2022, then rose by 3.44% to $20.3 million in 2023, then fell by 26.05% to $15.0 million in 2024, then dropped by 18.14% to $12.3 million in 2025.
- Its Research & Development was $12.3 million in Q3 2025, compared to $12.4 million in Q2 2025 and $15.2 million in Q1 2025.